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Advisor: Corrine K Hanson, PhD, RD, LMNT
OBJECTIVE: Little is known about the vitamin A status in mothers and infants at birth in the
United States. The main objective of this study is to determine associations between maternal
and infant serum retinol, provitamin A carotenoids, and non-provitamin A carotenoids. The
secondary aim is to explore the relationship between maternal intake and maternal and infant
serum levels of vitamin A compounds.
METHODS: This was a prospective cohort of 34 mothers and their infants admitted to the
neonatal intensive care unit (NICU). Maternal and cord blood samples were collected at delivery.
Serum retinol, lutein + zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, and β-carotene
concentrations were measured using high-performance liquid chromatography (HPLC). Food
frequency questionnaires (FFQs) were obtained to assess maternal dietary vitamin A intake.
Descriptive statistics and Spearman correlation coefficients were calculated. P-value <0.05 was
considered statistically significant.
RESULTS: The mean birth weight was 2738.0 ± 835.7 gm and mean gestational age was 36.7 ±
3.4 weeks. Vitamin A deficiency (VAD) was present in 71.9% of infants and 12.9% of mothers.
Significant positive correlations were found between maternal-infant serum lutein + zeaxanthin
(r=0.50, p=0.004), β-cryptoxanthin (r=0.83, p=<0.001), trans-lycopene (r=0.68, p=<0.001), cislycopene (r=0.52, p=0.003), total lycopene (r=0.63, p=<0.001), α-carotene (r=0.67, p=<0.001),
trans-β-carotene (r=0.74, p=<0.001), cis-β-carotene (r=0.44, p=0.013), total-β-carotene (r=0.71,
p=<0.001), and retinol (r=0.42, p=0.018).

CONCLUSION: VAD is a significant health problem in infants in the NICU. Infant vitamin A
status is correlated with maternal levels and may be influenced by maternal dietary intake
throughout pregnancy.
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CHAPTER 1: INTRODUCTION
Vitamin A is a key micronutrient for growth and development, making it especially
important for developing fetuses and infants. Vitamin A plays an important role in lung and
vision development, immune function, and overall cellular growth.1-4 Various provitamin A
carotenoids are thought to have specific characteristics including antioxidant properties,
immunoenhancement, and decreasing the risk of disorders that impact vision, aside from retinol
alone.5,6 Low dietary vitamin A intake is most strongly associated with health consequences
during infancy, childhood, pregnancy, and lactation due to the high nutritional demands at these
times of increased growth and development.7
Retinol levels of infants have been well-documented and have been considered the
standard serum measurement that determines vitamin A adequacy or deficiency. The World
Health Organization (WHO) estimates there are up to 122 countries with vitamin A deficiency
(VAD), affecting 190 million preschool-age children. In addition to children, it is estimated that
19.1 million pregnant women are deficient, thus putting their infants at risk of deficiency at birth.8
Worldwide, the focus has been to identify and target poorer countries. VAD is commonly
identified in the United States among the malnourished or chronically sick populations, but has
often been overlooked in pregnant women and infants. The presence of VAD within the
population of the United States has not been surveyed or identified by WHO. Because those
living in the United States have higher gross incomes and better access to food, it is assumed that
VAD is not a public health concern.7 This gap in knowledge warrants an evaluation of the
vitamin A status in pregnant women and infants in the United States.
In addition, little is known about the way carotenoids influence the outcomes of pregnant
women and their infants, recommendations for adequate intake, and normal serum levels. The
main objective of this study is to evaluate and determine associations between maternal and infant
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serum retinol, lutein + zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, and β-carotene levels at
birth. The secondary aim is to explore the relationship between maternal intake and maternal and
infant serum levels of vitamin A compounds.
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CHAPTER 2: BACKGROUND & REVIEW OF LITERATURE
OVERVIEW OF VITAMIN A
Structure, Metabolism and Storage:
Vitamin A is a fat soluble-vitamin that can be obtained from the diet in two forms,
preformed vitamin A or provitamin A carotenoids. Preformed vitamin A includes retinol and its
esterified form, retinyl ester. These can be found in animal sources such as dairy products, fish,
meat, and eggs and comprise ≥70% of the daily vitamin A intake in the United States.9
Provitamin A carotenoids are precursors for retinol and include β-carotene, α-carotene, and βcryptoxanthin. These must be obtained from the diet and are found in fruits, vegetables, and
oils.10 Provitamin A carotenoids provide ≤30% of the daily vitamin A intake in the United
States.9 Another group of carotenoids, non-provitamin A carotenoids, includes lutein, zeaxanthin,
and lycopene. This subset of carotenoids, though, cannot be converted into retinol.7,10,11 In
general, the term “vitamin A” is defined as the all-trans-retinol form.12
Retinol, retinal, and retinoic acid are the three active forms and retinyl ester is the storage
form of vitamin A. Absorption of preformed vitamin A occurs in the small intestine after retinyl
esters are compiled with triglycerides in micelles.10 Products of fat digestion and bile secretions
are essential in this process.13 If dietary fat intake is low, retinol and carotenoid absorption is
markedly reduced.13,14 Dietary retinoids can also be converted into retinoic acid in the intestine.
Efficiency of absorption of preformed vitamin A is 70-90%. As intake of these forms increases,
the absorbability remains high. Carotenoids are absorbed similarly to preformed vitamin A in the
intestinal lumen, but efficiency of absorption decreases as the amount of dietary carotenoids
increases. It has been reported that 9-22% of β-carotene ingested is absorbed. Once the vitamin
A forms are absorbed, they are transported to the liver via chylomicron remnants and mainly
stored as retinyl esters.10 The body stores approximately 80-90% of vitamin A in the liver as
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retinyl ester.12 Retinyl esters can be hydrolyzed into retinol as needed and transported to other
tissues when bound to retinol-binding protein (RBP). Carotenoids are integrated into very low
density lipoproteins (VLDL) to be sent throughout the bloodstream to other tissues.10 Figure 1
shows the metabolic pathways and conversion capabilities of different vitamin A forms.

Figure 1: Vitamin A Metabolism

Figure 1: Vitamin A Metabolism. Generalized pathways from intake of provitamin A carotenoids,
retinol, or retinyl esters for use in the body, storage, or elimination.12

Functions:
Vitamin A serves many important functions in the body and is crucial during periods of
growth and development. It is involved in regulating and promoting cell growth and
differentiation,3 maintaining the integrity of respiratory epithelial cells,4 visual development,
reproductive functions, and improving the immune system. Vitamin A is especially important in
fetal lung development and surfactant synthesis. In regards to vision, it is an important part of the
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photosensitive visual pigment complex in the retina.1 It is required for differentiation of the
cornea, conjunctival membranes, and photoreceptor rod and cone cells.10
According to the Institute of Medicine (IOM), the only known function of provitamin
carotenoids is vitamin A activity. Carotenoids are thought to have “antioxidant activity,
immunoenhancement, inhibition of mutagenesis and transformation, inhibition of premalignant
lesions, quenching of nonphotochemical fluorescence, and activity as a pigment in primate
macula.”15 β-carotene, specifically, has been documented to have antioxidant properties by
trapping free radicals and reducing oxidative stress or damage.1,2,5
The non-provitamin A carotenoids lutein, zeaxanthin, and lycopene have been shown to
function in the body, despite not being converted into retinol. It is thought that lutein and
zeaxanthin influence the maturation of cells in the macular region of the retina16 and protect
against stress and oxidation in the retinal pigment epithelium.6 This region is responsible for
developing central visual acuity. There also appears to be a link between lutein and zeaxanthin
and improved cognitive function. Vishwanathan et al. determined that the mean concentration of
lutein was significantly greater than the other carotenoids in brain tissue samples of infants who
died within the first 18 months of life (p=<0.05). Preterm infants also had significantly lower
concentrations of lutein and zeaxanthin compared to term infants in most of the brain regions
(p=<0.05). These findings in addition to previous research help support the role lutein and
zeaxanthin play in visual and cognitive development.16 Little is known about the function of
lycopene in pregnant women and infants. It is thought that lycopene can act as an antioxidant,11
impact immune development, and protect against inflammatory diseases.6 In general, lycopene
has been associated with benefits in cardiovascular disease, neurological disorders, and cancer.17
Oxidative stress that commonly occurs in infants in the neonatal intensive care unit
(NICU) is associated with many conditions such as bronchopulmonary dysplasia (BPD),
respiratory distress, retinopathy of prematurity (ROP), and necrotizing enterocolitis (NEC), as

6

well as an increased risk of infection.18 Ensuring adequate vitamin A status at birth, particularly
specific vitamin A forms found to decrease oxidative stress, may provide protective benefits to
infants at an increased risk of developing these conditions or positively impact an infant’s
recovery from these complications.
Dietary Reference Intakes:
The Dietary Reference Intakes (DRIs) established by the IOM are available for vitamin A for
different age categories ranging from infants to older adults. The DRIs are reported in retinol
activity equivalents (RAE). Retinol and provitamin A carotenoids are converted into common
units of RAE to accommodate the different bioactivities. Lutein, zeaxanthin, and lycopene, on
the other hand, cannot be converted into RAE, thus they do not possess vitamin A activity.
Conversion rates are used to determine RAE in food and supplements as nutrition facts labels and
supplement labels currently report vitamin A in international units (IUs).7 Knowing the source is
necessary to determine appropriate conversions to RAE. The following are conversion rates
between IUs and RAE:


1 IU retinol = 0.3 µg RAE



1 IU β-carotene from dietary supplements = 0.15 µg RAE



1 IU β-carotene from food = 0.05 µg RAE



1 IU α-carotene or β-cryptoxanthin = 0.025 µg RAE7

Vitamin A intake may also be measured in µg which can also be converted into RAE. The
following are conversion rates between an RAE and µg for specific vitamin A forms:


1 µg RAE = 1 µg retinol



1 µg RAE = 2 µg β-carotene in oil



1 µg RAE = 12 µg β-carotene in mixed foods
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1 µg RAE = 24 µg other provitamin A carotenoids in mixed foods19
The DRIs for vitamin A are displayed in Table 1. In adult females 19 years and older, the

Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA) for
vitamin A is 500 µg RAE/day and 700 µg RAE/day, respectively. In pregnant women, vitamin A
needs increase to 550 µg RAE/day for the EAR and 770 µg RAE/day for the RDA. Increased
needs during pregnancy take into account accumulation of vitamin A in the liver of the fetus
during gestation. The Tolerable Upper Intake Level (UL) for non-pregnant and pregnant women
is 3000 µg/day of preformed vitamin A.10
The Adequate Intake (AI) for vitamin A in infants 0-6 months is 400 µg RAE/day. The
AI for infants is established from the mean human milk intake in healthy breastfed infants,
assuming an average total human milk intake of 0.78 L/day. The average concentration of
vitamin A in human milk is 1.70 mmol/L. The UL for infants is defined at a level of 600 µg
RAE/day of preformed vitamin A.10

Table 1: Dietary Reference Intakes for Infants and Women
Age Group
Infants 0-6 months
Women ≥19 years
Pregnant Women ≥19 years
Lactation ≥19 years

EAR

RDA

500
550
900

700
770
1300

AI
400

UL
600
3000
3000
3000

The Dietary Reference Intakes for vitamin A as reported by the Institute of Medicine.
Values are reported in µg RAE/day of vitamin A.10

There are currently no established DRIs for carotenoids. The IOM concluded in their
most recent report in 2000 that existing evidence was insufficient to establish recommended
intake values. Current research cannot exclude the possibility of other substances found in
carotenoid-rich food being the parts that are contributing to health benefits. The IOM, though,
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does support recommendations for increasing consumption of carotenoid-rich fruits and
vegetables.15
In a report by Strobel et al., β-carotene needs are increased during pregnancy and the
breastfeeding period. It was recommended that β-carotene intake should be one third higher
during pregnancy and 0.7 mg/day higher during lactation than that for non-pregnant or nonbreastfeeding women.14

VITAMIN A DEFICIENCY
VAD is associated with a high risk of xerophthalmia and can cause childhood
blindness.20 Immunity can also be compromised if deficient, especially in infants, due to the
reduction in the function of neutrophils, macrophages, and natural killer cells as well as
interference with the regeneration of damaged mucosal barriers.9 VAD contributes to morbidity
and mortality from infections.8
VAD can be diagnosed by a clinical presentation of xerophthalmia and may be the only
assessment method if serum retinol concentrations cannot be obtained. Xerophthalmia
encompasses night blindness, conjunctival xerosis, Bitot’s spots, corneal xerosis, corneal
ulceration and necrosis, corneal scarring, and xerophthalmic fundus.8
Although an individual may not be showing clinical signs of deficiency such as
xerophthalmia and night blindness, subclinical VAD can also be present. This can contribute to
increased susceptibility to infections, reduced physical growth, and decreased survival from
serious illness. Populations at risk of subclinical VAD may include those living at or below the
poverty level, those with inadequate health care and immunizations, those with other nutritional
deficiencies, recent immigrants or refugees from countries with a high incidence of deficiency,
and those with ineffective fat digestion.21
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Assessing liver reserves is considered the gold standard to measure adequacy or
deficiency of vitamin A, but this method is not feasible in humans.22 Plasma retinol levels,
though, can be indicative of vitamin A status and liver reserves. If hepatic vitamin A reserves are
adequate, there will be little change in the concentration of retinol in the blood. The hepatic
stores must be depleted before a decline in plasma levels is detected. If serum retinol levels are
<1.05 µmol/L, storage levels are likely reduced.12
In 1980, a serum retinol level <0.35 µmol/L was used by WHO to define VAD among
children younger than six years of age and was associated with an increased prevalence of clinical
signs of deficiency. The cut-off level was then raised in 1996 after consensus by members of
WHO. It was believed that using <0.35 µmol/L was too low to identify individuals at risk for
subclinical consequences of deficiency, but had not yet displayed clinical signs of severe
deficiency. Serum retinol levels <0.70 µmol/L are now considered deficient, while levels <0.35
µmol/L are indicative of a severe deficiency where liver stores have been depleted.23
A serum retinol level >1.05 µmol/L has been proposed by WHO as an adequate
concentration for vitamin A status among pregnant and lactating women.8 This cut-off value has
been utilized in various research studies to determine adequate vs. inadequate vitamin A levels in
mothers and infants.20,24-26 Radhika et al. discovered that spontaneous preterm delivery and
anemia were significantly associated with serum retinol <20 µg/dL (<0.70 µmol/L) and
recommended maintaining levels >20 µg/dL (>0.70 µmol/L) at a minimum.27
An additional test that has been used to assess vitamin A status in infants is the relative
dose-response (RDR) test. Weinman et al. used it to assess vitamin A status of 124 newborn
preterm infants <37 weeks gestational age. To perform the RDR test, blood samples in newborn
infants were obtained before and 5 hours after an intramuscular injection of 5000 IU of vitamin
A. It is expected that this amount would increase the serum retinol levels by 10-20% if hepatic
reserves are normal. A positive RDR test was defined as retinol levels increasing >20% at >/= 5
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hours after administration, indicative of deficient liver vitamin A stores. When deficiency was
defined as <20 µg/dL (0.70 µmol/L), the test underestimated the number of deficient
infants. Using <30 µg/dL (1.05 µmol/L) as a deficient level, the test overestimated
VAD. Weinman et al. concluded that <25 µg/dL (0.87 µmol/L) was more appropriate for
defining VAD.28
Although clear worldwide deficiency standards are lacking for infants and pregnant
women, recommendations by WHO are generally recognized internationally. Overall,
populations are defined as severely deficient (<0.35 µmol/L), deficient (0.35-0.70 µmol/L), low
(0.70-1.05 µmol/L), or adequate (>1.05 µmol/L) based upon their serum retinol levels.8,25,29
The level of public health significance of VAD in a population has been established by
WHO. Deficiency is considered mild if ≥2-<10%, moderate if ≥10-<20%, or severe if ≥20% of
children 6-71 months of age have serum retinol concentrations 0.70 µmol/L or lower.23 Figures
2-3 demonstrate the public health significance of VAD in preschool-age children and pregnant
women in the world when evaluating serum retinol concentrations. A clinical presentation of
night blindness can also be used to define the level of public health significance of VAD. A mild,
moderate, and severe deficiency affects >0-<1%, ≥1-<5%, and ≥5% of children 24-71 months of
age, respectively, if night blindness is present.8
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Figure 2.1: Vitamin A Deficiency in Preschool-age Children

Figure 2.1: Vitamin A Deficiency in Preschool-age Children. Public health significance of global
vitamin A deficiency in preschool-age children based upon the World Health Organization’s survey
data of retinol levels <0.70 µmol/L from 1995-2005.8

Public health significance of global vitamin A deficiency in preschool-age children based upon the

Figure
2.2: Estimated Vitamin A Deficiency in Preschool-age Children
World Health Organization’s survey data of retinol levels <0.70 µmol/L from 1995-2005.8

Figure 2.2: Estimated Vitamin A Deficiency in Preschool-age Children. Public health significance
of global vitamin A deficiency in preschool-age children based upon the World Health Organization’s
survey data and regression-based estimates of retinol levels <0.70 µmol/L from 1995-2005.8
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Figure 3.1: Vitamin A Deficiency in Pregnant Women

Figure 3.1: Vitamin A Deficiency in Pregnant Women. Public health significance of global vitamin
A deficiency in pregnant women based upon the World Health Organization’s survey data of retinol
levels <0.70 µmol/L from 1995-2005.8

Figure 3.2: Estimated Vitamin A Deficiency in Pregnant Women

Figure 3.2: Estimated Vitamin A Deficiency in Pregnant Women. Public health significance of
global vitamin A deficiency in pregnant women based upon the World Health Organization’s survey
data and regression-based estimates of retinol levels <0.70 µmol/L from 1995-2005.8
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Efforts have been made in poorer countries to increase vitamin A intake through diet,
supplementation, and fortification. In 1995, WHO estimated that deficiency was a public health
significance in 60 countries and likely a problem in an additional 13 countries. Newer estimates
reflecting the time period of 1995-2005 indicate that 45 countries have VAD based on the
prevalence of night blindness and 122 countries based on serum retinol concentrations <0.70
µmol/L in preschool children.8
In a survey conducted between 1995 and 2005 in countries with a 2005 gross domestic
product (GDP) <$15,000, 15.3% of pregnant women (95% CI: 7.4-23.2) had serum retinol levels
below 0.70 µmol/L. This accounts for 19.1 million pregnant women. Preschool-age children
were also evaluated with 33.3% (95% CI: 31.1-35.4) deficient which translated into 190 million
children affected. When evaluating the six WHO regions, the prevalence of deficiency in
pregnant women was highest in the Western Pacific region (21.5%; 4.90 million), South-East
Asia (17.3%; 6.69 million), the Eastern Mediterranean region (16.1%; 2.42 million), Africa
(13.5%; 4.18 million), Europe (11.6%; 0.72 million), and the Americas (2.0%; 0.23 million). In
preschool-age children, the prevalence was highest in South-East Asia (49.9%; 91.5 million),
Africa (44.4%; 56.4 million), the Eastern Mediterranean region (20.4%; 13.2 million), Europe
(19.7%; 5.81 million), the Americas (15.6%; 8.68 million), and the Western Pacific region
(12.9%; 14.3 million).8 VAD contributes to 1.2-3.0 million deaths in children, and leads to the
development of xerophthalmia in 4.4 million children and 6.2 million mothers each year.30
The main underlying cause of deficiency is a diet insufficient in vitamin A. The risk of
health consequences is greatly increased if there is low vitamin A intake during periods of growth
and development such as pregnancy, infancy, and childhood.8 VAD in infants can develop when
their mothers are deficient during pregnancy or during lactation if infants are breastfed, when
infants receive diets offering very few sources of vitamin A, and/or when infants suffer from
ongoing illnesses contributing to malnutrition, malabsorption, and increased catabolism.31
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MATERNAL AND CORD BLOOD VITAMIN A LEVELS
Maternal-fetal Transfer:
The growing embryo and fetus require circulating maternal vitamin A for developmental
needs since there is no de novo synthesis of vitamin A. This transfer occurs through the placenta,
the maternal-fetal barrier. The placenta is thought to be the storage site for vitamin A until the
embryonic liver is functional.32 Fetal liver stores then tend to increase with increasing gestational
age, typically doubling between the 25th and 37th week gestation.18 Building fetal liver stores
is still strongly dependent on the vitamin A status of the mother.14 The placenta also serves to
release retinol to the fetus when maternal dietary intake is low or to store extra retinol to prevent a
toxic excess from maternal retinoids. The process of placental transfer is not clear. Possible
mechanisms include direct transfer of the retinol-RBP complex, transfer of free retinol, or cellular
uptake of retinol by a specific receptor Stra6.32
β-carotene from maternal blood may also reach the fetus through placental uptake of βcarotene-containing chylomicrons, VLDL, and low density lipoproteins (LDL). Spiegler et al.
hypothesized that “maternally circulating β-carotene can be delivered to the developing tissues
and there cleaved to generate retinoic acid in situ.”32 This may be beneficial in times of
insufficient dietary intake of other vitamin A compounds.
Relationship of Vitamin A Status in Mothers and Infants:
Various studies have evaluated retinol concentrations in mothers and infants at birth. It
has been reported that maternal and cord blood retinol and carotenoid concentrations are directly
correlated14 and are significantly higher in mothers than in cord blood levels (p<0.0001).33 βcarotene levels, specifically, in mothers have been found to be significantly higher and correlate
with cord blood levels.32 Limited research is available describing the relationship of the other
provitamin A and non-provitamin A carotenoids between mothers and infants.

15

Saunders et al. described retinol blood levels in 217 mothers and 222 infants born at a
mean gestational age of 39 ± 1.7 weeks in Rio de Janeiro, Brazil. VAD was defined as serum
levels <1.05 µmol/L in both mothers and infants. The mean postpartum level in mothers was
1.70 ± 0.86 µmol/L with 24.4% of the mothers being vitamin A deficient. The mean
concentration in umbilical cord blood was 1.29 ± 0.75 µmol/L, and the prevalence of VAD was
45.5%. Placental transfer of vitamin A, or the ratio of infant to maternal serum concentration,
was 75.9%.24 Another study in Recife, Brazil of 65 term normal birth weight infants (>2500
grams) determined the mean serum retinol levels at birth to be 1.46 ± 0.63 µmol/L in mothers and
1.13 ± 0.60 µmol/L in infants. Placental transfer was similar to the previous study in Rio de
Janeiro, Brazil at 77.4%. Although the mean retinol concentrations were considered normal in
both groups, 23.1% of infants and 23% of mothers were considered deficient in the sample when
VAD was defined as <0.70 µmol/L in infants and <1.05 µmol/L in mothers. The serum retinol
concentrations of infants was also positively correlated with maternal serum retinol
concentrations (r=0.27, p=0.04).25
Comparisons have been made between serum retinol levels in mothers after delivery and
non-pregnant women from the same community in South Africa as well as newborns with a mean
gestational age of 38.9 ± 1.9 weeks and preschool children from the same community. The mean
serum retinol level for mothers was 1.03 ± 0.40 µmol/L, while non-pregnant women had a mean
level of 1.93 ± 0.50 µmol/L. Newborns and preschool children had mean retinol levels of 0.73 ±
0.24 µmol/L and 1.10 ± 0.27 µmol/L, respectively. There were 49.3% of infants and 21.4% of
mothers with retinol levels <0.70 µmol/L. A significant positive correlation was found between
serum retinol concentrations in the mothers and newborns (r=0.227, p=0.001).34
In healthy mothers and infants with a mean gestational age of 39.5 ± 1.6 weeks in China,
mean maternal vitamin A concentration was 1.13 ± 0.371 µmol/L and cord blood levels were
0.69 ± 0.162 µmol/L. Of the mothers, 16.8% were considered to be deficient with levels below
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0.70 µmol/L as well as 36.4% had low levels ranging between 0.70 and 1.05 µmol/L. Of the
infants, 41.3% were deficient and 56.6% had a low vitamin A status. The mean placental transfer
of vitamin A was 78.3 ± 35.2%.20
Infant birth weight has thought to also influence vitamin A levels in infants. Agarwal et
al. discovered mean serum retinol levels were 13.3 ± 8.2 µg/dL (0.47 ± 0.29 µmol/L) in 146 low
birth weight infants (<2500 grams) and 14.0 ± 6.2 µg/dL (0.49 ± 0.22 µmol/L) in 79 normal birth
weight infants (≥2500 grams) in India (p=0.51). Deficiency in infants was defined as retinol
levels <10 µg/dL (<0.35 µmol/L). Of the low birth weight and normal birth weight infants,
41.1% and 24.1%, respectively, were vitamin A deficient. Mean maternal levels were 39.0 ± 15.5
µg/dL (1.36 ± 0.54 µmol/L) for mothers of low birth weight infants and 38.1 ± 16.3 µg/dL (1.33
± 0.57 µmol/L) for mothers of normal birth weight infants (p=0.69). VAD defined as <20 µg/dL
(0.70 µmol/L) in mothers was present in 11.5% of low birth weight and 9.0% of normal birth
weight infants’ mothers. Placental transfer was 34.1% for low birth weight infants and 36.7% in
normal birth weight infants.35
Vitamin A Status – Data Exclusive to Infants Only:
In a study evaluating 350 infants weighing <1250 grams at birth at the University of
Washington who had a serum retinol concentration measured in the first 28 days of life, 55% had
vitamin A levels <0.35 µmol/L. Mean retinol concentrations were not reported.4 Kositamongkol
et al. also evaluated 31 very low birth weight infants (<1500 grams) at birth in Thailand. The
median retinol level at birth was 15.5 µg/dL (IQR 10.5-24.9 µg/dL) (0.54 µmol/L (IQR 0.37-0.87
µmol/L)). The deficiency rate in this group was 67.7% when VAD was defined as retinol levels
<20 µg/dL (<0.70 µmol/L). Severe VAD with concentrations <10 µg/dL (<0.35 µmol/L) was
present in 19% of the infants.3
In a study of 56 infants <33 weeks gestational age in Finland, 22 infants were found to
have low vitamin A levels (<1.05 µmol/L) in umbilical cord samples with two of those subjects
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being deficient (<0.70 µmol/L). Tammela et al. also compared serum levels of infants whose
mothers either received or did not receive multivitamin supplementation during pregnancy. The
serum levels of infants of mothers who did not use supplements were not significantly different
from those that did with serum levels of 1.19 µmol/L and 1.29 µmol/L, respectively (p=0.273).26
Vitamin A Status – Data Exclusive to Mothers Only:
Throughout pregnancy, serum vitamin A levels in mothers tend to decrease as plasma
volume expands in the later trimesters. Normal maternal serum levels were found to be 25.6 ±
7.6 µg/dL (0.90 ± 0.27 µmol/L) in the first trimester, 24.0 ± 7.8 µg/dL (0.84 ± 0.27 µmol/L) in
the second trimester, 24.6 ± 9.3 µg/dL (0.86 ± 0.33 µmol/L) in the third trimester, and 35.3 ± 8.9
µg/dL (1.23 ± 0.31 µmol/L) postpartum.36 The Third National Health and Nutrition Examination
Survey (NHANES III) collected from 1988-1994 reported mean serum retinol levels in pregnant
women to be 1.47 µmol/L.10 In a study by Radhika et al., 736 women in their third trimester of
pregnancy in India were enrolled to evaluate VAD. The mean serum retinol level of mothers was
27.1 ± 11.4 µg/dL (0.95 ± 0.40 µmol/L). Thirty-five percent of mothers had an adequate vitamin
A status when defined as serum retinol levels ≥30 µg/dL (≥1.05 µmol/L). A small portion of the
mothers (3.5%) were considered severely deficient with levels <10 µg/dL (<0.35 µmol/L). It was
recommended that mothers obtain serum retinol levels >20 µg/L (>0.70 µmol/L) during
pregnancy to avoid increased complications including preterm delivery, moderate to severe
anemia, and pregnancy-induced hypertension.27
Relationship of Carotenoids in Mothers and Infants:
Although many research studies have evaluated serum retinol concentration levels,
information on the serum levels of carotenoids is limited. A study in Germany evaluated 151
maternal and 200 cord blood samples to assess the different vitamin A forms in maternal and cord
blood at birth. Infants had a mean gestational age of 39.1 ± 1.5 weeks, 10% of the infants were
born preterm (<37 weeks), and 8.5% had a low birth weight (<2500 grams). The mean maternal
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and cord retinol levels, respectively, were 1.15 µmol/L (95% CI: 1.09, 1.21) and 0.90 µmol/L
(95% CI: 0.85, 0.95) (r=0.099, p=0.228), lutein levels were 0.528 µmol/L (95% CI: 0.494, 0.563)
and 0.021 µmol/L (95% CI: 0.014, 0.030) (r=0.368, p=<0.001), zeaxanthin levels were 0.111 ±
0.056 µmol/L and undetectable, β-cryptoxanthin levels were 0.399 ± 0.259 µmol/L and
undetectable, lycopene levels were 1.08 ± 0.429 µmol/L and undetectable, α-carotene levels were
0.323 µmol/L (95% CI: 0.277, 0.376) and 0.004 µmol/L (95% CI: 0.003, 0.005) (r=0.668,
p=<0.001), and β-carotene levels were 0.755 µmol/L (95% CI: 0.675, 0.845) and 0.013 µmol/L
(95% CI: 0.010, 0.017) (r=0.832, p=<0.001). Comparisons were also made between preterm and
term infants. The only statistically significant finding between preterm and term infants was
retinol concentrations, 0.70 vs. 0.90 µmol/L (p<0.001) for preterm and term infants, respectively.
Lutein (0.01 vs 0.03 µmol/L, p=0.268), α-carotene (0.00 vs. 0.00 µmol/L, p=0.963), and βcarotene (0.02 vs. 0.01 µmol/L, p=0.531) were not significantly different in the preterm and term
infants, respectively. Zeaxanthin, β-cryptoxanthin, and lycopene were all below the limit of
detection in the cord blood samples. Maternal lutein (r=0.368, p=<0.001), α-carotene (r=0.668,
p=<0001), and β-carotene (r=0.832, p=<0.001) levels were positively correlated with cord blood
samples.18
A study in Ireland assessed retinol and carotenoid concentrations in 66 samples from
mothers and 40 cord blood samples from infants with a mean birth weight of 3439 ± 486 grams.
The mean levels in mothers and cord blood, respectively, were 1.88 ± 0.4 µmol/L and 1.01 ± 0.3
µmol/L of retinol, 0.46 ± 0.2 µmol/L and 0.13 ± 0.1 µmol/L of lutein + zeaxanthin (n=38
detectable cord blood samples), 0.14 ± 0.1 µmol/L and 0.04 ± 0.03 µmol/L of β-cryptoxanthin,
0.40 ± 0.2 µmol/L and 0.04 ± 0.03 µmol/L of lycopene (n=12 detectable cord blood samples),
0.23 ± 0.1 µmol/L and 0.04 ± 0.03 µmol/L of β-carotene (n=18 detectable cord blood samples),
and 0.05 ± 0.03 µmol/L and 0.01 ± 0.01 µmol/L of α-carotene (n=8 detectable cord blood
samples). Cord retinol concentrations were 53.7% of maternal concentrations.33
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From the NHANES III data, the mean serum level of each specific carotenoid was
reported for adult females. Women ages 19-30 and 31-50, respectively, had mean β-carotene
levels of 15.0 and 21.7 µg/dL, mean α-carotene levels of 3.44 and 5.37 µg/dL, mean βcryptoxanthin levels of 7.33 and 8.84 µg/dL, mean lutein + zeaxanthin levels of 18.6 and 21.4
µg/dL, and mean lycopene levels of 24.8 and 22.9 µg/dL.15
Carotenoid Status – Data Exclusive to Infants Only:
In a study assessing vitamin A status in 100 cord blood samples from normal birth weight
infants in Hawaii (mean birth weight was 3411.6 ± 464.3 grams), mean retinol was 209 ± 55
ng/mL (0.73 ± 0.19 µmol/L), total trans lutein + trans zeaxanthin was 30 ± 16 ng/mL (30 ± 16
µg/L), α-cryptoxanthin was 5 ± 2 ng/mL (5 ± 2 µg/L), trans-β-cryptoxanthin was 12 ± 15 ng/mL
(12 ± 15 µg/L), total lycopene was 12 ± 6 ng/mL (12 ± 6 µg/L), trans-α-carotene was 2 ± 2
ng/mL (2 ± 2 µg/L), trans-β-carotene was 7 ± 17 ng/mL (7 ± 17 µg/L), cis-β-carotene was 0.9 ± 2
ng/mL (0.9 ± 2 µg/L), and total carotenoids was 99 ± 56 ng/mL (99 ± 56 µg/L).2 Carotenoids
were also measured in 83 preterm and term infants at birth in Germany in a study by Sommerburg
et al. Median plasma concentrations at birth of cryptoxanthin were 11 µg/L (8-12 µg/L),
lycopene were 16 µg/L (14-18 µg/L), α-carotene were 5 µg/L (0-8 µg/L), and β-carotene were 24
µg/L (19-31 µg/L).5

MATERNAL VITAMIN A INTAKE
The nutritional status of mothers throughout pregnancy and at birth is one of the most
important factors that influence the nutritional status of infants at birth. Vitamin A stores in
infants are affected by maternal vitamin A intake while pregnant.37 Changes in maternal vitamin
A intake affect the circulating vitamin A levels, thus influencing the availability of vitamin A to
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transfer to the fetus via the placenta.32 Mothers can also influence their infant’s vitamin A status
postpartum if breast feeding their infant.37
Little is known about maternal intake of vitamin A during pregnancy. Weinman et al.
administered a qualitative questionnaire reflecting intake during gestation to 124 mothers at birth
in Brazil. It assessed intake from green, orange or yellow vegetables, fruits, milk, dairy products,
and meat (liver and fish). Information on vitamin A supplementation during pregnancy was also
obtained and showed that 7.3% of mothers took oral vitamin A supplementation. The
questionnaire revealed that 74.2% of mothers consumed a satisfactory amount of food rich in
vitamin A, although the satisfactory criteria was not defined.28
Another study in Finland by Tammela et al. administered 10-item structured
questionnaires to 11 mothers of preterm infants with low (<1.05 µmol/L) concentrations of
vitamin A in cord blood and 25 mothers of preterm infants with normal (>1.05 µmol/L)
concentrations of vitamin A in cord blood. The questionnaires assessed the frequency of
consumption of liver products, carrots and vegetables, and butter and vegetable fats. The dietary
habits did not differ between mothers whose infants had low vitamin A concentrations and those
that had normal vitamin A concentrations. The questionnaire revealed that 91% of mothers of
infants with low vitamin A status and 56% of mothers of infants with normal vitamin A status
consumed liver products 0-1 times/month. It also showed that 45% of mothers of infants with
low vitamin A status and 28% of mothers of infants with normal vitamin A status ate carrots 0-1
times/week. Vegetables were consumed less than 5 times/week in 18% of mothers of infants with
low vitamin A status and in 56% of mothers of infants with normal vitamin A status. Lastly, the
questionnaire showed that 54% of mothers of infants with low vitamin A status and 44% of
mothers of infants with normal vitamin A status consumed vegetable fat.26
In a sample of 683 pregnant mothers in Israel, 24 hour dietary questionnaires were given
to assess nutritional status during pregnancy. Mean and median vitamin A intake was 531.0 ±
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94.1 µg RAE and 237.1 µg RAE, respectively. The IOM’s EAR of 550 µg RAE was used for
adequate vitamin A intake. Of the mothers, 88% had vitamin A intake below the EAR.38
The NHANES III data estimated the mean vitamin A intake for pregnant women to be
757 µg RAE/day. Dietary intake information was also obtained on carotenoids. Pregnant women
consumed on average 376 µg of α-carotene, 1531 µg β-carotene, 159 µg β-cryptoxanthin, 1455
µg lutein + zeaxanthin, and 8713 µg lycopene based on the usual intake from food for one day.10

INFANT VITAMIN A INTAKE
Estimations of vitamin A intake have been reported in various populations of infants after
birth. A prospective cohort of 35 very low birth weight infants (<1500 grams) in Thailand
estimated vitamin A intake from parenteral nutrition, enteral feedings of breast milk or formula,
and supplementation. Median daily vitamin A intake was 1066 IU/day (IQR 893.7-1337 IU/day)
or 820 IU/kg/day (IQR 698-1122 IU/kg/day) from birth to the time of full feeding. From time of
full feeding to term postmenstrual age, the median vitamin A intake was 1585 IU/day (IQR 11691893 IU/day) or 832 IU/kg/day (IQR 516.3-1087 IU/kg/day). Information was not available to
differentiate the percentage of vitamin A intake from each source of nutrition.3
Souza et al. described differences in vitamin A intake between term and preterm infants
(<37 weeks gestation) who were exclusively breastfed with no supplements by mothers in Brazil.
Breast milk samples were analyzed to determine the vitamin A intake. Term and preterm infants
had an average intake of 352.64 ± 152.72 µg of retinol/day and 217.65 ± 105.65 µg of retinol/day,
respectively. With these groups, 46.3% of term and 72.5% of preterm infants did not consume
adequate amounts of vitamin A, which was defined as 400 µg/day, as established by the IOM’s
DRIs. This is likely influenced by the concentration of retinol in the breast milk of mothers who
had term vs. preterm infants and the volumes consumed. The mean retinol concentration of
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breast milk was significantly higher in mothers of term infants (1.87 ± 0.81 µmol/L) compared to
preterm infants (1.38 ± 0.67 µmol/L) (p<0.0001).39 The American Academy of Pediatrics has
recommended that preterm infants should consume 210-450 µg retinol/kg each day.14
In a research study conducted in China, the vitamin A status of infants aged 0-2 months
was evaluated. Infants were evaluated based upon their form of nutrition received. The groups
included mix-fed, artificially fed, and breast fed infants. For mix-fed infants, the mean and
median intakes of vitamin A were 662 ± 12.8 µg/day and 543 µg/day, respectively. Only 0.4% of
the infants in this group were inadequate for vitamin A when compared to the EAR in China of
375 µg/day. When evaluating possible toxicity levels in mix-fed infants, 38.2% were above the
UL of 600 µg/day. Infants who were solely receiving artificial formula had a mean vitamin A
intake of 627 ± 26.8 µg/day and median intake of 644 µg/day. The artificially fed group had
21.5% who did not meet the EAR, but also had over half of the group exceeding the UL (53.5%).
Breast fed infants had mean vitamin A intakes lower than that of the artificially fed and mix-fed
infants, although the specific data for this group was not reported.40
In order to appropriately provide recommendations and care to pregnant women and
infants to prevent VAD, an evaluation of maternal and infant serum vitamin A compound levels,
prevalence of VAD, and maternal dietary intake of vitamin A compounds in the United States is
needed.
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CHAPTER 3: METHODS
STUDY DESIGN AND POPULATION
This prospective cohort was conducted to evaluate vitamin A status in infants and
mothers at birth. All infants admitted to the NICU at Nebraska Medicine and their mothers were
eligible for enrollment. Written informed consent was obtained from a parent for each infant
enrolled. Exclusion criteria included infants with congenital abnormalities, inborn errors of
metabolism, gastrointestinal, liver, or kidney disease, anemia, and those that required blood
transfusions. Infants were also excluded if the parents were under the age of 19 years or if infants
were made wards of the State of Nebraska. The study protocol was approved by the University of
Nebraska Medical Center Institutional Review Board.

DATA AND BLOOD COLLECTION
Thirty-four mother-infant pairs were enrolled into the study. Maternal and umbilical cord
blood samples were collected at the time of delivery. Samples were processed efficiently after
collection, protected from heat and light, and stored in -80˚ F freezers until they were analyzed.
Analysis of samples was performed at the Biomarker Research Institute at the Harvard School of
Public Health. Measurements of lutein + zeaxanthin, β-cryptoxanthin, trans-lycopene, cislycopene, total lycopene, α-carotene, trans-β-carotene, cis-β-carotene, total-β-carotene, and
retinol were obtained. Concentrations in plasma samples were measured as described by ElSohemy et al. Plasma samples (250 µL) were mixed with 250 mL ethanol containing 10 ug ractocopherol/mL (Tocol) as an internal standard, extracted with 4 mL hexane, evaporated to
dryness under nitrogen, and reconstituted in 100 mL ethanol-dioxane (1:1, by vol) and 150 mL
acetonitrile. Samples are quantitated by high-performance liquid chromatography (HPLC) on a
Restek Ultra C18 150 mm X 4.6 mm column with a 3-µm particle size encased in a column oven
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(Hitachi L-2350, Hitachi, San Jose, CA) to prevent temperature fluctuations, and equipped with a
trident guard cartridge system (Restek, Corp. Bellefonte, PA). A mixture of acetonitrile,
tetrahydrofuran, methanol, and a 1% ammonium acetate solution (68:22:7:3) was used as the
mobile phase at a flow rate of 1.1 mL/min, with a Hitachi L-2130 pump in isocratic mode, a
Hitachi L-2455 diode array detector (300 nm and 445 nm), and a Hitachi L-2200 auto-sampler
with water-chilled tray. The Hitachi System Manager software (D-2000 Elite, Version 3.0) was
used for peak integration and data acquisition. Internal quality control was monitored with four
control samples analyzed within each run. These samples consisted of two identical high-level
plasmas and two identical low-level plasmas. Comparison of data from these samples allowed
for within-run and between-run variation estimates. In addition, external quality control was
monitored by participation in the standardization program for carotenoid analysis from the
National Institute of Standards and Technology U.S.A.41
Maternal baseline and clinical data was collected and included race, body mass index
(BMI), delivery mode, birth month, gestational diabetes mellitus, preeclampsia, placental
chorioamnionitis, serum vitamin A levels, and dietary intake. Infant baseline and clinical data
was collected and included sex, gestational age, birth weight and percentile, birth head
circumference and percentile, birth length and percentile, ROP, supplemental oxygen use,
intubation on admission, days on ventilator, BPD, respiratory distress syndrome (RDS), NEC,
intraventricular hemorrhage (IVH), positive blood cultures, and cord blood vitamin A levels. A
subject was noted to have any of the above conditions if a medical diagnosis was made during the
NICU stay in the electronic medical record.
Dietary intake throughout pregnancy was assessed by administering food frequency
questionnaires (FFQ) to the mothers. The FFQs encompassed typical intake from supplements,
food from all of the major food groups, and beverages over the past year. FFQs were analyzed
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using the Harvard nutrient-composition database which contains food composition values from
the United States Department of Agriculture.
VAD was defined according to WHO standards and categories used by Fernandes et al.
Infants and mothers were considered severely deficient (<0.35 µmol/L or <100 µg/L), deficient
(0.35-0.70 µmol/L or 100-200 µg/L), low (0.70-1.05 µmol/L or 200-300 µg/L), or adequate
(>1.05 µmol/L or >300 µg/L) based upon their serum retinol levels.8,25,29 Other investigators
have used similar concentrations as an indicator of VAD in infants and pregnant women.1,3,20,25,26

STATISTICAL ANALYSIS
Descriptive statistics were used for continuous and categorical variables. Continuous
variables (maternal BMI, serum vitamin A levels, and dietary intake information and infant
gestational age, birth weight and percentile, birth head circumference and percentile, birth length
and percentile, days on ventilator, and serum vitamin A levels) were described using means ±
standard deviations, medians, and ranges. For categorical variables (maternal race, delivery
mode, birth month, gestational diabetes mellitus, preeclampsia, and placental chorioamnionitis
and infant sex, ROP, supplemental oxygen use, intubation on admission, BPD, RDS, NEC, IVH,
and positive blood cultures), frequencies and percentages were reported.
Retinol levels were measured in µg/L and converted to µmol/L to reflect adequacy and
deficiency standards established by WHO. The conversion factor used was 286 µg retinol is
equivalent to 1 µmol retinol.19 Conversion factors were also used for carotenoids to make
comparisons to previous research findings according to the NHANES 2005-2006 data processing
protocol. The following conversions factors were used:


Lutein + zeaxanthin results in µg/L were converted into µmol/L by multiplying by
0.001758
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β-cryptoxanthin results in µg/L were converted into µmol/L by multiplying by 0.001810



Lycopene results in µg/L were converted into µmol/L by multiplying by 0.001863



α-carotene results in µg/L were converted into µmol/L by multiplying by 0.001863 and



β-carotene results in µg/L were converted into µmol/L by multiplying by 0.001863.42
Spearman correlation coefficients were used to describe associations between maternal

and cord blood vitamin A levels, maternal dietary intake and maternal and cord blood vitamin A
levels, gestational age and maternal and cord blood vitamin A levels, and birth weight and
maternal and cord blood vitamin A levels.
All tests were two-sided and a P-value <0.05 was considered statistically significant. All
statistical analyses were carried out using the Statistical Package for the Social Sciences software
(IBM SPSS Statistics; Version 22.0).
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CHAPTER 4: RESULTS
SUBJECT CHARACTERISTICS
Maternal and infant demographics and clinical information were obtained for all 34
mother-infant pairs. Characteristics of the study mothers and infants are presented in Tables 2-3.
Maternal Characteristics
Of the mothers enrolled, 64.7% were Caucasian, 17.6% Hispanic, 14.7% African
American, and 2.9% other/unknown race. Gestational diabetes mellitus, preeclampsia, and
placental chorioamnionitis were present in 17.6%, 20.6%, and 11.8% of mothers, respectively.
The mean BMI was 30.7 ± 6.3 kg/m2. Vaginal deliveries occurred in 47.1% of the births. All of
the births took place in the summer (29.4% in June, 41.2% in July, and 29.4% in August).
Infant Characteristics
The group of infants was comprised of 58.8% males and 41.2% females. The mean
gestational age was 36.7 ± 3.4 weeks. The mean birth weight was 2738.0 ± 835.7 gm (45.5 ±
33.3 %ile), mean length was 47.0 ± 4.6 cm (47.2 ± 34.4 %ile), and mean head circumference was
32.3 ± 2.6 cm (45.4 ± 33.5 %ile). Development of complications after birth in the infants
included ROP (2.9%), RDS (38.2%), BPD (2.9%), intubation on admission (26.5%),
supplemental oxygen use (41.2%), and a positive blood culture result (2.9%). Nine subjects were
on a ventilator for an average of 2.0 ± 2.3 days throughout their NICU stay.
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Table 2: Maternal Baseline Characteristics
Categorical Demographics (n=34)
Race
Caucasian
Hispanic
African American
Other/Unknown
Delivery Mode
Vaginal
Cesarean
Birth Month
June
July
August
Gestational Diabetes Mellitus
Preeclampsia
Placental Chorioamnionitis
Continuous Demographics
BMI (kg/m2) (n=34)
Serum Vitamin A Levels (n=31)
lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)
retinol (µmol/L)
Dietary Intake (n=20)
Calorie Intake (kcals)
Protein Intake (gm)
Carbohydrate Intake (gm)
Fat Intake (gm)
Retinol Activity
Equivalents (RAE) (µg)
lutein + zeaxanthin (µg)
β-cryptoxanthin (µg)
total lycopene (µg)
α-carotene (µg)
total-β-carotene (µg)
retinol (IU)

n (%)
22 (64.7)
6 (17.6)
5 (14.7)
1 (2.9)
16 (47.1)
18 (52.9)
10 (29.4)
14 (41.2)
10 (29.4)
6 (17.6)
7 (20.6)
4 (11.8)
Mean ± SD
30.7 ± 6.3

Median
29.6

Range
18.0-42.1

163.3 ± 91.7
73.5 ± 53.0
243.9 ± 107.4
200.9 ± 81.4
444.9 ± 186.2
48.4 ± 72.9
186.4 ± 221.6
14.5 ± 16.1
200.9 ± 237.5
326.3 ± 140.8
1.14 ± 0.49

140.3
59.9
222.8
194.9
424.1
18.1
104.6
7.5
113.2
288.2
1.01

45.1-443.8
8.7-285.7
35.6-438.5
36.7-378.8
72.3-795.8
4.6-388.4
21.4-968.9
1.7-67.8
23.1-1036.7
146.5-648.9
0.51-2.27

2600.3 ± 991.3
104.1 ± 32.3
343.1 ± 157.5
95.1 ± 35.4

2323.7
108.7
299.0
89.9

1314.0-4415.6
44.9-157.4
165.6-710.7
39.0-161.7

1799.9 ± 613.6

1937.4

422.3-2721.7

2761.7 ± 1894.5
218.5 ± 183.2
5362.8 ± 5273.4
620.5 ± 1056.6
5039.2 ± 3806.7
3403.6 ± 1837.1

2060.2
130.7
3637.2
267.8
4336.6
3243.3

852.4-6937.0
45.0-629.5
1072.0-24654.1
17.4-4719.5
430.8-15661.6
756.1-7490.8
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Table 3: Infant Baseline Characteristics
Categorical Demographics (n=34)

n (%)

Sex
Male
Female
Retinopathy of Prematurity (ROP)
Supplemental Oxygen Use
Intubation on Admission
Bronchopulmonary Dysplasia (BPD)
Respiratory Distress Syndrome (RDS)
Necrotizing Enterocolitis (NEC)
Intraventricular hemorrhage (IVH)
Positive blood culture
Continuous Demographics (n=34)

20 (58.8)
14 (41.2)
1 (2.9)
14 (41.2)
9 (26.5)
1 (2.9)
13 (38.2)
0 (0)
0 (0)
1 (2.9)
Mean ± SD

Median

Range

Gestational Age (weeks)
Birth weight (gm)
Birth weight Percentile
Birth Head Circumference (cm)
Birth Head Circumference Percentile
Birth Length (cm)
Birth Length Percentile
Days on Ventilator (n=9)
Cord Blood Vitamin A Levels (n=32)
lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)
retinol (µmol/L)

36.7 ± 3.4
2738.0 ± 835.7
45.5 ± 33.3
32.3 ± 2.6
45.4 ± 33.5
47.0 ± 4.6
47.2 ± 34.4
2.0 ± 2.3

37.1
2850.0
43.4
32.7
43.3
47.0
48.5
1.0

30.3-42.0
840.0-4109.0
0.0-98.8
25.0-37.0
0.0-99.6
35.0-55.0
0.0-99.7
1.0-8.0

25.4 ± 11.4
9.3 ± 5.7
11.5 ± 6.3
10.3 ± 5.3
21.8 ± 11.4
5.4 ± 4.5
15.1 ± 15.4
3.1 ± 2.5
18.3 ± 17.3
172.0 ± 43.0
0.60 ± 0.15

24.6
7.9
10.5
9.2
19.5
4.5
10.1
2.3
12.4
180.5
0.63

9.5-57.7
2.4-25.8
3.6-26.0
2.9-24.0
6.5-48.5
0.0-18.8
0.0-70.3
0.0-10.0
0.0-75.9
98.1-255.9
0.34-0.89
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VITAMIN A STATUS
Maternal and cord blood samples were collected and analyzed for 31 mothers and 32
infants. Maternal and cord blood levels are displayed in Tables 2-3. Vitamin A status of mothers
and infants according to WHO classification is shown in Table 4 and Figure 4.
Maternal Status
The mean maternal serum retinol level was 326.3 ± 140.8 µg/L (1.14 ± 0.50 µmol/L).
Categorical placement of retinol levels revealed 41.9%, 45.2%, and 12.9% of mothers had
adequate, low, and deficient vitamin A status, respectively. The mean lutein + zeaxanthin level
was 163.3 ± 91.7 µg/L, β-cryptoxanthin was 73.5 ± 53.0 µg/L, trans-lycopene was 243.9 ± 107.4
µg/L, cis-lycopene was 200.9 ± 81.4 µg/L, total lycopene was 444.9 ± 186.2 µg/L, α-carotene
was 48.4 ± 72.9 µg/L, trans-β-carotene was 186.4 ± 221.6 µg/L, cis-β-carotene was 14.5 ± 16.1
µg/L, and total-β-carotene was 200.9 ± 237.5 µg/L.
Infant Status
At birth, 71.9% of infants were vitamin A deficient with 3.1% of those being severely
deficient. The remaining 28.1% of infants had low vitamin A status. None of the subjects had
levels >1.05 µmol/L. The mean cord retinol level was 172.0 ± 43.0 µg/L (0.60 ± 0.15 µmol/L).
The mean lutein + zeaxanthin level was 25.4 ± 11.4 µg/L, β-cryptoxanthin was 9.3 ± 5.7 µg/L,
trans-lycopene was 11.5 ± 6.3 µg/L, cis-lycopene was 10.3 ± 5.3 µg/L, total lycopene was 21.8 ±
11.4 µg/L, α-carotene was 5.4 ± 4.5 µg/L, trans-β-carotene was 15.1 ± 15.4 µg/L, cis-β-carotene
was 3.1 ± 2.5 µg/L, and total-β-carotene was 18.3 ± 17.3 µg/L.
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Table 4: Prevalence of Vitamin A Deficiency
n (%)

Infants (n = 32)
Severely Deficient
(<0.35 µmol/L or <100 µg/L)

1 (3.1)

Deficient
(0.35-0.70 µmol/L or 100-200 µg/L)

22 (68.8)

Low
(0.70-1.05 µmol/L or 200-300 µg/L)

9 (28.1)

Adequate
(>1.05 µmol/L or >300 µg/L)

0 (0)

Mothers (n = 31)
Severely Deficient
(<0.35 µmol/L or <100 µg/L)

0 (0)

Deficient
(0.35-0.70 µmol/L or 100-200 µg/L)

4 (12.9)

Low
(0.70-1.05 µmol/L or 200-300 µg/L)

14 (45.2)

Adequate
(>1.05 µmol/L or >300 µg/L)

13 (41.9)

Figure 4: Maternal and Infant Serum Vitamin A Status
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Number of subjects

20

15
Infants

10

Mothers

5

0
Severely Deficient
<0.35 µmol/L
(<100 µg/L)

Deficient
0.35-0.70 µmol/L
(100-200 µg/L)

Low
0.70-1.05 µmol/L
(200-300 µg/L)

Adequate
>1.05 µmol/L
(>300 µg/L)

Figure 4: Maternal and Infant Serum Vitamin A Status. Maternal and infant retinol levels categorized
into severely deficient, deficient, low, and adequate vitamin A status.
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Relationship between Serum Vitamin A Levels of Mothers and Infants:
Associations between maternal and cord blood were determined and are displayed in
Table 5. Levels were positively correlated for lutein + zeaxanthin (r=0.50, p=0.004), βcryptoxanthin (r=0.83, p=<0.001), trans-lycopene (r=0.68, p=<0.001), cis-lycopene (r=0.52,
p=0.003), total lycopene (r=0.63, p=<0.001), α-carotene (r=0.67, p=<0.001), trans-β-carotene
(r=0.74, p=<0.001), cis-β-carotene (r=0.44, p=0.013), total-β-carotene (r=0.71, p=<0.001), and
retinol (r=0.42, p=0.018). Figures 5-10 display the significant correlations for the main
carotenoids (lutein + zeaxanthin, β-cryptoxanthin, total lycopene, α-carotene, and total-βcarotene) and retinol.

Table 5: Correlations of Maternal and Infant Vitamin A Concentrations

lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)

Correlation Coefficient
0.50
0.83
0.68
0.52
0.63
0.67
0.74
0.44
0.71
0.42

P-value
0.004
<0.001
<0.001
0.003
<0.001
<0.001
<0.001
0.013
<0.001
0.018
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Cord Blood Levels (µg/L)

Figure 5: Relationship of Maternal-Infant Serum Lutein + Zeaxanthin
Concentrations

Maternal Blood Levels (µg/L)
Figure 5: Relationship of Maternal-Infant Serum Lutein + Zeaxanthin
Concentrations. Positive correlation between maternal and infant cord blood lutein +
zeaxanthin levels (r=0.50; p=0.004).
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Cord Blood Levels (µg/L)

Figure 6: Relationship of Maternal-Infant Serum β-Cryptoxanthin Concentrations

Maternal Blood Levels (µg/L)
Figure 6: Relationship of Maternal-Infant Serum β-Cryptoxanthin Concentrations.
Positive correlation between maternal and infant cord blood β-cryptoxanthin levels
(r=0.83; p=<0.001).

35

Cord Blood Levels (µg/L)

Figure 7: Relationship of Maternal-Infant Serum Total Lycopene Concentrations

Maternal Blood Levels (µg/L)
Figure 7: Relationship of Maternal-Infant Serum Total Lycopene Concentrations.
Positive correlation between maternal and infant cord blood total lycopene levels (r=0.63;
p=<0.001).
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Cord Blood Levels (µg/L)

Figure 8: Relationship of Maternal-Infant Serum α-Carotene Concentrations

Maternal Blood Levels (µg/L)

Figure 8: Relationship of Maternal-Infant Serum α-Carotene Concentrations. Positive
correlation between maternal and infant cord blood α-Carotene levels (r=0.67; p=<0.001).
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Cord Blood Levels (µg/L)

Figure 9: Relationship of Maternal-Infant Serum Total-β-Carotene Concentrations

Maternal Blood Levels (µg/L)

Figure 9: Relationship of Maternal-Infant Serum Total-β-Carotene Concentrations.
Positive correlation between maternal and infant cord blood total β-carotene levels (r=0.71;
p=<0.001).
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Cord Blood Levels (µg/L)

Figure 10: Relationship of Maternal-Infant Serum Retinol Concentrations

Maternal Blood Levels (µg/L)
Figure 10: Relationship of Maternal-Infant Serum Retinol Concentrations. Positive
correlation between maternal and infant cord blood retinol levels (r=0.42; p=0.018).

39

Positive significant associations between birth weight and maternal serum vitamin A
concentrations were found for β-cryptoxanthin (r=0.36, p=0.048), α-carotene (r=0.44, p=0.012),
trans-β-carotene (r=0.48, p=0.007), cis-β-carotene (r=0.50, p=0.004), and total-β-carotene
(r=0.49, p=0.005). Table 6 displays all correlations between birth weight and maternal serum
vitamin A concentrations. Figures 11-13 illustrate the associations between the main carotenoids
(β-cryptoxanthin, α-carotene, and total-β-carotene) with significant correlations. Significant
associations between birth weight and cord blood concentrations were also found for βcryptoxanthin (r=0.39, p=0.026), α-carotene (r=0.36, p=0.042), trans-β-carotene (r=0.42,
p=0.015), cis-β-carotene (r=0.44, p=0.012), total-β-carotene (r=0.44, p=0.012), and retinol
(r=0.73, p=<0.001). All correlations are shown in Table 7 for birth weight and cord blood
concentrations. Retinol was most strongly associated with birth weight and is presented in Figure
14.

Table 6: Correlations of Birth Weight and Maternal Vitamin A Concentrations

lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)

Correlation Coefficient
0.34
0.36
-0.12
-0.08
-0.11
0.44
0.48
0.50
0.49
0.17

P-value
0.065
0.048
0.532
0.665
0.570
0.012
0.007
0.004
0.005
0.361
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Maternal Β-Cryptoxanthin (µg/L)

Figure 11: Relationship of Birth Weight and Maternal β-Cryptoxanthin
Concentrations

Birth Weight (gm)
Figure 11: Relationship of Birth Weight and Maternal β-Cryptoxanthin
Concentrations. Positive correlation between birth weight and maternal serum
β-cryptoxanthin levels (r=0.36; p=0.048).
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Maternal α-Carotene (µg/L)

Figure 12: Relationship of Birth Weight and Maternal α-Carotene Concentrations

Birth Weight (gm)
Figure 12: Relationship of Birth Weight and Maternal α-Carotene Concentrations.
Positive correlation between birth weight and maternal serum α-carotene levels (r=0.44;
p=0.012).
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Maternal Total-β-Carotene (µg/L)

Figure 13: Relationship of Birth Weight and Maternal Total-β-Carotene
Concentrations

Birth Weight (gm)
Figure 13: Relationship of Birth Weight and Maternal Total-β-Carotene
Concentrations. Positive correlation between birth weight and maternal serum total-βcarotene levels (r=0.49; p=0.005).
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Table 7: Correlations of Birth Weight and Infant Vitamin A Concentrations

lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)

Correlation Coefficient
0.21
0.39
-0.11
-0.10
-0.07
0.36
0.42
0.44
0.44
0.73

P-value
0.250
0.026
0.553
0.600
0.715
0.042
0.015
0.012
0.012
<0.001

Infant Retinol (µg/L)

Figure 14: Relationship of Birth Weight and Infant Retinol Concentrations

Birth Weight (gm)

Figure 14: Relationship of Birth Weight and Infant Retinol Concentrations. Positive
correlation between birth weight and cord blood retinol levels (r=0.73; p=0.005).
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Gestational age and maternal β-cryptoxanthin was significantly positively correlated
(r=0.39, p=0.031) (Figure 15) as well as gestational age and infant β-cryptoxanthin (r=0.39,
p=0.026), cis-β-carotene (r=0.37, p=0.039), and retinol (r=0.55, p=0.001) (Figure 16). Table 8
and Table 9 show all correlations between gestational age and serum vitamin A concentrations for
mothers and infants, respectively.

Table 8: Correlations of Gestational Age and Maternal Vitamin A Concentrations

lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)

Correlation Coefficient
0.23
0.39
-0.11
-0.09
-0.11
0.22
0.27
0.35
0.28
-0.12

P-value
0.221
0.031
0.571
0.636
0.568
0.236
0.144
0.053
0.123
0.519
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Maternal Β-Cryptoxanthin (µg/L)

Figure 15: Relationship of Gestational Age and Maternal β-Cryptoxanthin
Concentrations

Gestational Age (weeks)
Figure 15: Relationship of Gestational Age and Maternal β-Cryptoxanthin
Concentrations. Positive correlation between gestational age and maternal serum βcryptoxanthin levels (r=0.39; p=0.031).
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Table 9: Correlations of Gestational Age and Infant Vitamin A Concentrations

lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg/L)
trans-lycopene (µg/L)
cis-lycopene (µg/L)
total lycopene (µg/L)
α-carotene (µg/L)
trans-β-carotene (µg/L)
cis-β-carotene (µg/L)
total-β-carotene (µg/L)
retinol (µg/L)

Correlation Coefficient
0.25
0.39
0.01
0.02
0.04
0.18
0.31
0.37
0.33
0.55

P-value
0.173
0.026
0.949
0.929
0.826
0.323
0.083
0.039
0.063
0.001

Infant Retinol (µg/L)

Figure 16: Relationship of Gestational Age and Infant Retinol Concentrations

Gestational Age (weeks)

Figure 16: Relationship of Gestational Age and Infant Retinol Concentrations. Positive
correlation between gestational age and cord blood retinol levels (r=0.55; p=0.001).
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MATERNAL VITAMIN A INTAKE
FFQs were completed for 21 mothers, but data from 20 FFQs were used for analysis
(Table 2). FFQ data from one mother was excluded due to results of calorie intake (31727 kcals)
exceeding expected amount. The median daily energy intake was 2323.7 kcals (1314.0-4415.6
kcals). Median macronutrient intake of protein, carbohydrates, and fat were 108.7 gm (44.9157.4 gm), 299.0 gm (165.6-710.7 gm), and 89.9 gm (39.0-161.7 gm), respectively. Median
daily RAE was 1937.4 µg (422.3-2721.7 µg). Median retinol intake was 3243.3 IU (756.17490.8 IU. Specific median carotenoid intake was 2060.2 µg (52.4-6937.0 µg) of lutein +
zeaxanthin, 130.7 µg (45.0-629.5 µg) of β-cryptoxanthin, 3637.2 µg (1072.0-24654.1 µg) of
lycopene, 267.8 µg (17.4-4719.5 µg) of α-carotene, and 4336.6 µg (430.8-15661.6 µg) of βcarotene.
Correlations between dietary intake and maternal and cord blood concentrations of
vitamin A compounds are displayed in Tables 10-11. Maternal intake of specific vitamin A
forms was found to be significantly associated with maternal and cord blood levels. Intake of
lutein + zeaxanthin was positively associated with maternal serum α-carotene (r=0.47, p=0.047)
and β-carotene (r=0.48, p=0.045). Dietary α-carotene was positively associated with maternal
serum α-carotene (r=0.52, p=0.029). β-carotene intake was also positively associated with
maternal serum β-carotene (r=0.47, p=0.050) and α-carotene (r=0.50, p=0.034). One significant
negative association was found between RAE intake and maternal serum β-cryptoxanthin (r=0.51, p=0.031). Maternal intake of lutein + zeaxanthin and β-carotene was significantly
correlated with cord blood α-carotene levels (r=0.55, p=0.015 and r=0.63, p=0.004, respectively).
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Table 10: Correlations of Maternal Intake of Vitamin A and Maternal Blood Levels
Dietary intake vs. Serum Level
lutein + zeaxanthin (µg) vs. lutein + zeaxanthin (µg/L)
lutein + zeaxanthin (µg) vs. β-cryptoxanthin (µg/L)
lutein + zeaxanthin (µg) vs. total lycopene (µg/L)
lutein + zeaxanthin (µg) vs. α-carotene (µg/L)
lutein + zeaxanthin (µg) vs. total-β-carotene (µg/L)
lutein + zeaxanthin (µg) vs. retinol (µg/L)
β-cryptoxanthin (µg) vs. β-cryptoxanthin (µg/L)
β-cryptoxanthin (µg) vs. lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg) vs. total lycopene (µg/L)
β-cryptoxanthin (µg) vs. α-carotene (µg/L)
β-cryptoxanthin (µg) vs. total-β-carotene (µg/L)
β-cryptoxanthin (µg) vs. retinol (µg/L)
lycopene (µg) vs. total lycopene (µg/L)
lycopene (µg) vs. lutein + zeaxanthin (µg/L)
lycopene (µg) vs. β-cryptoxanthin (µg/L)
lycopene (µg) vs. α-carotene (µg/L)
lycopene (µg) vs. total-β-carotene (µg/L)
lycopene (µg) vs. retinol (µg/L)
α-carotene (µg) vs. α-carotene (µg/L)
α-carotene (µg) vs. lutein + zeaxanthin (µg/L)
α-carotene (µg) vs. β-cryptoxanthin (µg/L)
α-carotene (µg) vs. total lycopene (µg/L)
α-carotene (µg) vs. total-β-carotene (µg/L)
α-carotene (µg) vs. retinol (µg/L)
β-carotene (µg) vs. total-β-carotene (µg/L)
β-carotene (µg) vs. lutein + zeaxanthin (µg/L)
β-carotene (µg) vs. β-cryptoxanthin (µg/L)
β-carotene (µg) vs. total lycopene (µg/L)
β-carotene (µg) vs. α-carotene (µg/L)
β-carotene (µg) vs. retinol (µg/L)
retinol (IU) vs. retinol (µg/L)
retinol (IU) vs. lutein + zeaxanthin (µg/L)
retinol (IU) vs. β-cryptoxanthin (µg/L)
retinol (IU) vs. total lycopene (µg/L)
retinol (IU) vs. α-carotene (µg/L)
retinol (IU) vs. total-β-carotene (µg/L)
RAE (µg) vs. lutein + zeaxanthin (µg/L)
RAE (µg) vs. β-cryptoxanthin (µg/L)
RAE (µg) vs. total lycopene (µg/L)
RAE (µg) vs. α-carotene (µg/L)
RAE (µg) vs. total-β-carotene (µg/L)
RAE (µg) vs. retinol (µg/L)

Correlation
Coefficient
0.31
0.27
-0.15
0.47
0.48
-0.05
0.16
-0.11
0.27
-0.12
-0.02
-0.07
0.38
0.19
0.21
0.14
0.31
0.09
0.52
0.33
0.13
-0.17
0.46
0.32
0.47
0.25
0.19
-0.16
0.50
0.28
-0.07
-0.20
-0.18
-0.22
-0.14
-0.03
-0.30
-0.51
0.03
0.00
0.06
0.14

P-value
(*significant)
0.205
0.278
0.550
0.047*
0.045*
0.858
0.518
0.677
0.281
0.633
0.942
0.772
0.119
0.458
0.404
0.573
0.216
0.738
0.029*
0.188
0.598
0.499
0.058
0.203
0.050*
0.326
0.450
0.407
0.034*
0.263
0.779
0.435
0.486
0.378
0.592
0.909
0.222
0.031*
0.906
0.997
0.804
0.581
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Table 11: Correlations of Maternal Intake of Vitamin A and Cord Blood Levels
Dietary intake vs. Serum Level
lutein + zeaxanthin (µg) vs. lutein + zeaxanthin (µg/L)
lutein + zeaxanthin (µg) vs. β-cryptoxanthin (µg/L)
lutein + zeaxanthin (µg) vs. total lycopene (µg/L)
lutein + zeaxanthin (µg) vs. α-carotene (µg/L)
lutein + zeaxanthin (µg) vs. total-β-carotene (µg/L)
lutein + zeaxanthin (µg) vs. retinol (µg/L)
β-cryptoxanthin (µg) vs. β-cryptoxanthin (µg/L)
β-cryptoxanthin (µg) vs. lutein + zeaxanthin (µg/L)
β-cryptoxanthin (µg) vs. total lycopene (µg/L)
β-cryptoxanthin (µg) vs. α-carotene (µg/L)
β-cryptoxanthin (µg) vs. total-β-carotene (µg/L)
β-cryptoxanthin (µg) vs. retinol (µg/L)
lycopene (µg) vs. total lycopene (µg/L)
lycopene (µg) vs. lutein + zeaxanthin (µg/L)
lycopene (µg) vs. β-cryptoxanthin (µg/L)
lycopene (µg) vs. α-carotene (µg/L)
lycopene (µg) vs. total-β-carotene (µg/L)
lycopene (µg) vs. retinol (µg/L)
α-carotene (µg) vs. α-carotene (µg/L)
α-carotene (µg) vs. lutein + zeaxanthin (µg/L)
α-carotene (µg) vs. β-cryptoxanthin (µg/L)
α-carotene (µg) vs. total lycopene (µg/L)
α-carotene (µg) vs. total-β-carotene (µg/L)
α-carotene (µg) vs. retinol (µg/L)
β-carotene (µg) vs. total-β-carotene (µg/L)
β-carotene (µg) vs. lutein + zeaxanthin (µg/L)
β-carotene (µg) vs. β-cryptoxanthin (µg/L)
β-carotene (µg) vs. total lycopene (µg/L)
β-carotene (µg) vs. α-carotene (µg/L)
β-carotene (µg) vs. retinol (µg/L)
retinol (IU) vs. retinol (µg/L)
retinol (IU) vs. lutein + zeaxanthin (µg/L)
retinol (IU) vs. β-cryptoxanthin (µg/L)
retinol (IU) vs. total lycopene (µg/L)
retinol (IU) vs. α-carotene (µg/L)
retinol (IU) vs. total-β-carotene (µg/L)
RAE (µg) vs. lutein + zeaxanthin (µg/L)
RAE (µg) vs. β-cryptoxanthin (µg/L)
RAE (µg) vs. total lycopene (µg/L)
RAE (µg) vs. α-carotene (µg/L)
RAE (µg) vs. total-β-carotene (µg/L)
RAE (µg) vs. retinol (µg/L)

Correlation
Coefficient
0.09
0.22
-0.09
0.55
0.39
0.29
0.01
-0.09
0.04
-0.03
-0.16
-0.16
0.06
0.26
0.23
0.05
0.05
0.17
0.34
0.12
0.15
-0.29
0.18
0.23
0.38
0.06
0.24
-0.13
0.63
0.27
-0.01
0.00
-0.07
-0.23
-0.32
0.02
-0.09
-0.29
0.07
-0.04
0.11
0.11

P-value
(*significant)
0.726
0.359
0.716
0.015*
0.103
0.226
0.977
0.729
0.875
0.901
0.518
0.502
0.814
0.288
0.351
0.844
0.836
0.488
0.149
0.616
0.542
0.232
0.450
0.355
0.110
0.803
0.333
0.611
0.004*
0.257
0.969
0.997
0.770
0.355
0.179
0.943
0.710
0.223
0.764
0.864
0.658
0.658
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CHAPTER 5: DISCUSSION
VITAMIN A STATUS IN MOTHERS AND INFANTS
The mean retinol level in infants, indicative of vitamin A adequacy or deficiency, was
172.0 µg/L (0.60 µmol/L). This is considered deficient according to WHO standards.8 None of
the infants had adequate levels >1.05 µmol/L. These findings are concerning considering WHO
has not acknowledged VAD as a problem and has not evaluated the prevalence in infants or
preschool-age children in the United States. Some studies evaluating infants with mean normal
birth weights or mean gestational ages >37 weeks, similar to our subjects, have reported retinol
cord levels of 0.49-0.73 µmol/L in the United States (Hawaii), China, and India,2,20,43 which are
consistent with our findings. Others have found higher levels at 0.90-1.29 µmol/L in Germany,
Brazil, and Ireland.18,24,25,33 Preterm infants have even been found to have higher levels ranging
from 1.19-1.29 µmol/L in Finland.26 Very low or low birth weight infants, though, have been
found to be deficient with cord blood concentrations of 0.47-0.54 µmol/L in India and
Thailand.3,43 Retinol concentrations in cord blood are still variable throughout the world and
between infants of different birth weights and gestational ages. It has been proposed that the
normal retinol concentration for newborn infants is between 0.7-2.5 µmol/L.44 Assessing levels
in the United States, especially different regions of the country, will help define the level of
public health significance and thus allow health professionals to appropriately screen and provide
interventions to prevent or treat VAD.
VAD is more prevalent than expected in the infants in our study. The prevalence of
VAD when defined as serum retinol concentrations <0.70 µmol/L has been previously reported to
affect 23.1-49.3% of infants with normal birth weights and gestational ages in Brazil, China, and
South Africa,20,25,34 3.6% of infants <33 weeks gestational age in Finland,26 and 67.7% of very
low birth weight infants in Thailand.3 In addition, 45.5% of healthy infants in Brazil had VAD
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when retinol levels were <1.05 µmol/L.24 Roughly 3 out of 4 infants in our study had VAD,
despite nearly 42% of mothers having adequate retinol levels. Low retinol levels in infants at
birth could be expected because the fetal liver is only able to store a small amount of vitamin A
during pregnancy,14 but does not explain the degree of deficiency in our study.
The maternal-fetal placental transfer was 53%, consistent with 52-55% placental transfers
previously reported33,43,44 and a proposed estimated ratio of maternal to fetal plasma
concentrations in healthy pregnancies of 2:1.1 Cord retinol levels at 50-60% of maternal levels
have been suggested to represent a normal range for infants at birth.44 Researchers in Brazil and
China, though, have reported higher retinol placental transfer rates of 75-78%.20,24,25 Even when
comparing infants of low and normal birth weights, rates have not varied between the two groups.
Agarwal et al. discovered a placental transfer of 34% in low birth weight infants and 37% in
normal birth weight infants, both findings much lower than the results of our study.35
WHO has expanded the serum range for what is considered deficient to include those
with retinol levels <0.70 µmol/L, which identifies more mothers and infants with VAD. This
cutoff value was raised from <0.35 µmol/L in 1996 after members of WHO thought it was too
low to identify those with subclinical signs of deficiency.23 It has been suggested that defining
VAD as retinol levels <0.70 µmol/L may not apply for mothers and infants right after delivery
due to the acute phase response as a result of the birth process and the hemodilution of
pregnancy.34 However, this change appears to be appropriate as even a subclinical deficiency that
can be present with retinol levels <0.70 µmol/L has been shown to negatively impact health and
increase the risk of infections, reduce growth, and decrease survival from serious illnesses.21
Early identification could lead to earlier interventions and potentially improve health outcomes.
Even a low vitamin A level should be acted upon to decrease the likelihood of a deficiency from
developing, especially in infants. Infants already have low liver stores at birth to begin with and

52

these can be quickly depleted in a couple of days if experiencing a sudden stressful health event,
malabsorption state, or fasting state.14
In mothers, low retinol levels throughout pregnancy influence the developing fetus and
contribute to VAD in infants at birth. The mean maternal retinol level in our study was 326.3
µg/L (1.14 µmol/L). Despite this adequate vitamin A concentration, nearly 13% of mothers were
deficient (<0.70 µmol/L), with another 45% with low levels (0.70-1.05 µmol/L). This is
especially concerning given the placental transfer is only approximately 50%. A few studies have
found similar maternal retinol levels between 1.13-1.23 µmol/L18,20,36 while others have found
higher concentrations of 1.33-1.88 µmol/L24,25,33,43 including the NHANES III data where
pregnant women had mean retinol levels of 1.47 µmol/L, reflective of the United States
population.10 Retinol levels in mothers in our study and previous research appear to be variable,
which may be a result of environmental factors such as vitamin A intake. It may be crucial to
evaluate maternal nutritional status throughout pregnancy in order to optimize vitamin A intake
and thus vitamin A status in the mother and the developing fetus.
Carotenoid Status:
The carotenoid status in mothers and infants at birth has not been evaluated nearly to the
extent that retinol levels have been, especially in the United States. Reference intervals are not
currently established for carotenoid concentrations in plasma. There is no data available to our
knowledge reporting maternal and infant carotenoid concentrations in the Midwest region. All
carotenoids evaluated were measurable in all subjects except one who had undectable levels of αcarotene and β-carotene. Weber et al. was unable to detect zeaxanthin, β-cryptoxanthin, and
lycopene levels in their cord blood samples.18 Over half the subjects in a study by Kiely et al.
also had undectable levels of lycopene, β-carotene, and α-carotene.33 Being able to identify levels
of all of the carotenoids in nearly all of the subjects may be a result of improvements in
technology used or be reflective of truly higher carotenoid levels in our sample.
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Compared to data obtained in Hawaii, this study demonstrated lower lutein + zeaxanthin
levels (25.4 µg/L vs. 30 µg/L) in infants, although Franke et al. measured the trans form only and
not total lutein + zeaxanthin. Β-cryptoxanthin levels were also lower in infants in this study (9.3
µg/L vs. 12 µg/L). The other carotenoid cord blood levels, total lycopene (21.8 µg/L vs. 12
µg/L), α-carotene (5.4 µg/L vs. 2 µg/L), and β-carotene (18.3 µg/L vs. 7.9 µg/L), were all higher
in the infants in the present study.2 More variability in carotenoid levels was found when
compared to a study by Sommerburg et al. Mean lycopene (21.8 µg/L vs. 16 µg/L), α-carotene
(5.4 µg/L vs. 5 µg/L), and β-carotene (18.3 µg/L vs. 24 µg/L) in this study were found to differ
when compared to median levels in infants in Germany.5
In our sample of mothers, all carotenoid levels measured were lower than those found in
a study by Weber et al. in Germany. Carotenoids in our study compared to the results of Weber
et al. for mothers at birth, respectively, are 0.287 µmol/L vs. 0.639 µmol/L for lutein +
zeaxanthin, 0.133 µmol/L vs. 0.399 µmol/L for β-cryptoxanthin, 0.829 µmol/L vs. 1.08 µmol/L
for total lycopene, 0.090 µmol/L vs. 0.323 µmol/L for α-carotene, and 0.374 µmol/L vs. 0.755
µmol/L for total β-carotene.18 However, our results compared to mothers in Ireland were mixed.
Our study demonstrated higher levels of total lycopene (0.829 µmol/L vs. 0.40 µmol/L), total βcarotene (0.374 µmol/L vs. 0.23 µmol/L) and α-carotene (0.090 µmol/L vs. 0.05 µmol/L) in
mothers and lower levels of lutein + zeaxanthin (0.287 µmol/L vs. 0.46 µmol/L). β-cryptoxanthin
concentrations, interestingly, were very similar (0.133 µmol/L vs. 0.14 µmol/L).33
The NHANES III serum carotenoids levels of general adult women, although not
exclusive to pregnant women, aligned fairly closely to the results of this study for β-carotene
(200.9 µg/L vs. 150-217 µg/L in NHANES III), α-carotene (48.4 µg/L vs. 34.4-53.7 µg/L in
NHANES III), β-cryptoxanthin (73.5 µg/L vs. 73.3-88.4 µg/L in NHANES III), and lutein +
zeaxanthin (163.3 µg/L vs. 186-214 µg/L in NHANES III). The one exception was the mothers
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in this study had higher lycopene levels at 444.9 µg/L compared to 229-248 µg/L in adult females
in the samples collected in NHANES III.15
Due to limited previous research on serum carotenoid levels in pregnant women and
infants at birth and no established reference values, the adequacy or deficiency in our sample was
difficult to determine.
Relationship between Serum Vitamin A Levels of Mothers and Infants:
Not only were maternal retinol levels significantly positively correlated with cord blood
levels, all measured carotenoids were as well. These significant findings provide further evidence
of the placental transfer of vitamin A compounds in utero. Fernandes et al. also found a
significant correlation with serum retinol levels (r=0.27, p=0.04),25 although Weber et al.
(r=0.099, p=0.228)18 and Kiely et al. did not (r=0.19).33 Previous research has also shown
positive correlations of maternal and infant lutein (r=0.368, p=<0.001), α-carotene (r=0.668,
p=<0.001), and β-carotene (r=0.832, p=<0.001).18 These results support the importance of
improving maternal levels throughout pregnancy in order to benefit the developing fetus.

MATERNAL VITAMIN A INTAKE
Because mothers influence the retinol and carotenoid concentrations of their infant via
placental transfer, it is important to determine which dietary vitamin A compounds influence
serum concentrations. This is the first study to date to our knowledge that thoroughly evaluates
the diets of mothers throughout pregnancy using a detailed FFQ and evaluates how dietary intake
of specific vitamin A compounds influences serum levels of mothers and infants. The median
vitamin A intake measured in RAE in our sample of mothers was 3.5 times the EAR and 2.5
times the RDA for pregnant women. It was also 2.5 times higher than the NHANES III intake
reports for pregnant women (1937.4 µg vs. 757 µg).10 Median RAE intake in our study was also
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well above the intake in mothers in Israel (1937.4 µg vs. 237.1 µg).38 Given that maternal
vitamin A intake greatly exceeded the DRIs, it could be expected to translate into adequate serum
levels. However, deficiency was still prevalent in our study population. Also RAE intake did not
correlate with serum retinol levels in both mothers and infants in our sample. The current DRIs
take into account a combination of all vitamin A compounds by converting to a common unit of
RAE, but this may not be a sufficient measure to assume adequate intake and thus adequate
serum levels.
In comparison to the NHANES III data, median intake of β-cryptoxanthin (130.7 µg vs.
159 µg), lycopene (3637.2 µg vs. 8713 µg), and α-carotene (267.8 µg vs. 376 µg) were all lower
in this study. Intake of lutein + zeaxanthin (2060.2 µg vs. 1455 µg) and β-carotene (4336.6 µg vs.
1531 µg) were the only carotenoids consumed in higher amounts in this study population than the
pregnant women evaluated in NHANES III.10 There may be specific dietary vitamin A
compounds that are important in optimizing vitamin A serum status. This has not been
previously explored. Interestingly, maternal dietary intake of lutein + zeaxanthin did not
statistically correlate with maternal serum lutein + zeaxanthin, but it did positively correlate with
serum α-carotene and β-carotene. Other correlations observed included maternal intake of αcarotene being significantly positively correlated with maternal serum α-carotene as well as being
positively correlated with serum β-carotene, although not statistically significant (p=0.058). βcarotene was also significantly positively correlated with both serum β-carotene and α-carotene.
None of the other dietary intake measures directly correlated with its corresponding serum
measure. These findings suggest that β- and α-carotenes influence serum levels similarly and
could be obtained in the diet from the same food source. This also brings into question how the
metabolism of each vitamin A compound may affect the others when consumed together. With
our earlier results that all serum levels of the vitamin A compounds correlated positively in cord
blood, it can be assumed that enhancing the serum vitamin A status in mothers will enhance the
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infant’s vitamin A status at birth. Due to only obtaining dietary intake information on 59% of our
subjects, dietary vitamin A intake in mothers may not be representative of the study population.
Further evaluations with larger samples need to be completed before stronger conclusions can be
drawn.
Not only is maternal dietary intake important throughout pregnancy, it continues to be
crucial after birth if infants are breast fed. Low dietary vitamin A intake and low serum
concentrations in mothers may lead to the development of VAD after birth or contribute to a
failure to form adequate vitamin A liver stores in later infancy and childhood.

IMPROVING VITAMIN A STATUS
The method to increase vitamin A status after birth is controversial. Various forms of
supplementation given to mothers and infants have been assessed. Pregnant women are advised
to avoid supplementing their diet with >10,000 IU of preformed vitamin A. These high dose
supplements have been associated with malformation of the fetus.21 Also, supplementation to
mothers during pregnancy has not shown beneficial effects on neonatal birth weight, length, and
head circumference.20 Given the risk of negative consequences of vitamin A toxicity from
supplementation, WHO does not recommend vitamin A supplementation during pregnancy to
prevent maternal and infant morbidity and mortality. However, in areas where VAD is a public
health issue, WHO recommends supplementing pregnant women with vitamin A to help prevent
gestational night blindness. In addition, WHO does not recommend supplementation for nursing
mothers, but encourages proper nutrition through a balanced diet.39 Improving breast milk
concentrations may help increase vitamin A intake for infants who are breast fed. Retinoids and
carotenoids are not homeostatically regulated in breast milk, thus higher dietary intake can
contribute to a higher composition in breast milk.45 Haftel et al. showed 130% and 200%
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increases in lycopene and β-carotene breast milk content, respectively, when mothers
supplemented their diet with carrot puree or mashed tomatoes.9
Infant intake through formula may also be an area to target to improve infant vitamin A
status. Sommerburg et al. evaluated breast milk and formula content and found that four major
carotenoids (α-carotene, β-carotene, lycopene, and cryptoxanthin) were detected in breast milk
samples, but formulas were lacking these vitamin A compounds. Of the eight formulas tested,
50% did not contain any of the carotenoids, 50% contained β-carotene, and 38% contained βcryptoxanthin.5 Rubin et al. determined that infants who received supplemented formula with
lutein + zeaxanthin, lycopene, and β-carotene had considerably higher corresponding plasma
levels.46 Adding vitamin A compounds to formula may be a feasible and safe way to improve
vitamin A status in infants. If a more aggressive treatment is needed for severe VAD, it may be
appropriate to administer higher doses of vitamin A. Supplementing infants with 5000 IU
vitamin A intramuscularly, three times per week for 28 days, has also been shown to improve
vitamin A levels and decrease the risk of chronic lung disease in very low birth weight
infants.3 Vitamin A supplementation is still debatable due to inconclusive research and may need
to be considered on an individual basis. Supplementation through carotenoids may be more
appropriate compared to supplementation of preformed vitamin A, but would need to be
evaluated further before general recommendations could be made.

LIMITATIONS
The limitations of this study should be considered. A larger sample size would have been
beneficial to establish more solid findings that could be generalized to a larger population. In
addition to the small sample of 34 mother-infant pairs enrolled, serum samples from three
mothers and cord blood samples from two infants were not obtained. Also, this study looked at
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subjects in the NICU, who are often under higher levels of stress due to an increase in health
complications. These results may not be consistent with healthy mother-infant pairs at birth.
The FFQs were also completed and analyzed in only 20 of the mothers. Almost half of
the mothers did not complete a FFQ, making it difficult to draw solid conclusions related to the
intake of vitamin A compounds. As with other intake assessment forms, self-reporting can lead
to both under or overestimations of intake. The FFQ also asked questions regarding the
frequency of intake of specific foods on average over the past year. With many vitamin Acontaining foods being seasonal, it may have been difficult for subjects to accurately fill out the
FFQ. The FFQ used, though, did provide a thorough intake assessment and has been used in
many other adult populations.
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CHAPTER 6: CONCLUSION
This is one of the first studies to not only evaluate vitamin A status from retinol levels,
but more importantly, assess the carotenoid status in mothers and infants at birth. Previously,
limited data has been available regarding the current status of the various vitamin A compounds
in the United States. This prospective study determined VAD is a significant problem in this
population of infants and is influenced by the maternal vitamin A status. In addition, maternal
intake may influence the serum levels of mothers and infants, although further research needs to
be completed to determine the influence of specific carotenoid intake on serum concentrations of
vitamin A compounds. Additional research evaluating vitamin A intake after birth including
dietary intake, supplementation of preformed vitamin A vs. carotenoids, or a combination would
provide an insight into how VAD can be prevented or corrected in early infancy and childhood.
With a larger sample in the future, comparisons could be made between different gestational ages
and birth weights, which may help target high risk populations.
Evaluating correlations of retinol and carotenoid concentrations between mothers and
infants provides important information to help determine appropriate strategies and specific
vitamin A components to target to improve vitamin A status in both parties. By increasing
awareness of the significant VAD present in NICU babies in the Midwest, appropriate
assessments and interventions can be implemented to provide optimal care and improve health
outcomes.
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